CLINICAL_TRIALS
withdrawal
· 2025-02-14
Clinical Trial Update: European Clinical Evaluation of the Carmat Total Artificial Heart [NA]
Summary
European clinical evaluation of the Carmat Total Artificial Heart has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Carmat SAS | Conditions: Advanced Heart Failure | NA | Status: SUSPENDED